Michael L. Volk

Baylor Scott & White - Central Texas Foundation — United States

Medicine · Health Sciences

46h-index8.5kcitations186works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease and Transplantation(104), Liver Disease Diagnosis and Treatment(88), Organ Transplantation Techniques and Outcomes(41), Hepatitis C virus research(25), Hepatocellular Carcinoma Treatment and Prognosis(23)

Publications183 total

AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and post-transplant management of non-graft–related complications
Liver Transplantation·2025· 1 cited
The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists
Journal of the American College of Cardiology·2025· 3 citedOpen Access
Exclusion of Liver Disease and Underutilization of Liver-Specific Endpoints in Heart Failure Trials
JACC Heart Failure·2025· 3 cited
Carvedilol is associated with lower mortality than other nonselective beta-blockers in patients with cirrhosis
Baylor University Medical Center Proceedings·2025· 2 cited
The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality
Hepatology·2025· 2 citedOpen Access
Portal vein thrombosis in patients with cirrhosis
Baylor University Medical Center Proceedings·2024· 2 citedOpen Access
Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study
Hepatology·2024· 9 cited
The Liver Frailty Index enhances mortality risk prediction above and beyond MELD 3.0 alone
Liver Transplantation·2024· 4 citedOpen Access
684 THE LIVER FRAILTY INDEX (LFI) IMPROVES MORTALITY RISK PREDICTION OVER MELD 3.0 ALONE FOR WOMEN, OLDER ADULTS, AND OBESE PATIENTS WITH CIRRHOSIS
Gastroenterology·2024
Innovations in health care delivery for patients with cirrhosis
Hepatology·2024· 2 cited
Preventing Readmissions of Hepatic Encephalopathy
Clinics in Liver Disease·2024
The liver frailty index is a predictor of healthcare utilization after liver transplantation in older adults
Clinical Transplantation·2023· 5 citedOpen Access
Association of body mass index with post‐liver transplant outcomes
Clinical Transplantation·2023· 5 citedOpen Access
S824 Endoscopic Screening and the Risk of Post Left Ventricular Assist Device Gastrointestinal Bleeding: A Multicenter Retrospective Cohort Study
The American Journal of Gastroenterology·2023
Outcomes and Resource Utilization in Liver Transplant Recipients Who Underwent Expedited Transplant Evaluation
Progress in Transplantation·2023· 1 cited
Lung cancer screening among liver transplant recipients
Liver Transplantation·2023
Association of Frailty With Health-Related Quality of Life in Liver Transplant Recipients
JAMA Surgery·2022· 31 citedOpen Access
Interhospital transfers resulting in liver transplantation: Clinical, regulatory, and economic issues
Clinical Liver Disease·2022· 1 citedOpen Access
Patient‐centered care: Key elements applicable to chronic liver disease
Hepatology·2022· 14 cited
The clinical value of angiopoietin‐2 in liver diseases
Clinical Liver Disease·2022· 3 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Anna S. Lok(12), Amit G. Singal(8), Andrés Duarte‐Rojo(8), Jorge A. Marrero(7), Elizabeth C. Verna(7), Jennifer C. Lai(7), Robert J. Fontana(6), Robert S. Rahimi(6), Matthew R. Kappus(6), Michael A. Dunn(6), Mara McAdams‐DeMarco(6), Daniela P. Ladner(6), Dorry L. Segev(6), Jessica L. Mellinger(6), Elliot B. Tapper(6), Daniel Ganger(5), Mina O. Rakoski(4), Sumeet K. Asrani(4), Jennifer L. Dodge(4), Gerald Scott Winder(4)